Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial - Krug, Lee M.; Manegold, Christian (The lancet. Oncology, 2015)
Gesehen am 15.11.2017